Fortis Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 29, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founders
- Bin Liu, Ph.D.
- Company Description
- Fortis Therapeutics is an immuno-oncology biotech developing a novel antibody-drug conjugate for late-stage multiple myeloma and metastatic castration-resistant prostate cancer. Fortis was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Bin Liu, Ph.D.
- Market
- Immuno-oncology
- Location
- La Jolla, California, USA
- Coinvestors
- avalon Ventures, Bregua Corporation, Lilly Asia Ventures, Myeloma Investment Fund, Osage University Partners, Prostate Cancer Foundation, Vivo Capital